Thomas P. Zimmerman

2.5k total citations
68 papers, 2.1k citations indexed

About

Thomas P. Zimmerman is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Thomas P. Zimmerman has authored 68 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 24 papers in Physiology and 21 papers in Epidemiology. Recurrent topics in Thomas P. Zimmerman's work include Adenosine and Purinergic Signaling (24 papers), Biochemical and Molecular Research (18 papers) and HIV/AIDS drug development and treatment (13 papers). Thomas P. Zimmerman is often cited by papers focused on Adenosine and Purinergic Signaling (24 papers), Biochemical and Molecular Research (18 papers) and HIV/AIDS drug development and treatment (13 papers). Thomas P. Zimmerman collaborates with scholars based in United States and United Kingdom. Thomas P. Zimmerman's co-authors include Gerald Wolberg, William B. Mahony, Barbara A. Domin, Karen Prus, Gail S. Duncan, L.‐C. Chu, Gertrude B. Elion, Marie A. Iannone, Michael J. Tisdale and Steven T. Russell and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Thomas P. Zimmerman

68 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas P. Zimmerman United States 26 1.1k 518 501 458 277 68 2.1k
D B Wasson United States 22 1.2k 1.0× 447 0.9× 450 0.9× 342 0.7× 576 2.1× 39 2.2k
L. Lee Bennett United States 28 1.5k 1.4× 419 0.8× 431 0.9× 494 1.1× 307 1.1× 80 2.3k
Joel V. Tuttle United States 18 889 0.8× 445 0.9× 216 0.4× 327 0.7× 113 0.4× 22 1.3k
George W. Koszalka United States 24 1.2k 1.1× 855 1.7× 306 0.6× 593 1.3× 356 1.3× 56 2.4k
Gurpreet S. Ahluwalia United States 21 780 0.7× 425 0.8× 135 0.3× 602 1.3× 111 0.4× 48 1.7k
Yutaka Natsumeda United States 29 2.1k 1.9× 957 1.8× 592 1.2× 723 1.6× 214 0.8× 65 2.7k
Mary Sue Colemán United States 25 1.3k 1.2× 457 0.9× 436 0.9× 255 0.6× 203 0.7× 79 2.1k
Mahmoud H. el Kouni United States 28 1.4k 1.3× 648 1.3× 241 0.5× 388 0.8× 616 2.2× 88 2.5k
G. A. LePage United States 29 1.7k 1.5× 418 0.8× 373 0.7× 352 0.8× 300 1.1× 106 2.4k
Jiří Veselý Czechia 21 881 0.8× 180 0.3× 76 0.2× 318 0.7× 192 0.7× 157 1.7k

Countries citing papers authored by Thomas P. Zimmerman

Since Specialization
Citations

This map shows the geographic impact of Thomas P. Zimmerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas P. Zimmerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas P. Zimmerman more than expected).

Fields of papers citing papers by Thomas P. Zimmerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas P. Zimmerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas P. Zimmerman. The network helps show where Thomas P. Zimmerman may publish in the future.

Co-authorship network of co-authors of Thomas P. Zimmerman

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas P. Zimmerman. A scholar is included among the top collaborators of Thomas P. Zimmerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas P. Zimmerman. Thomas P. Zimmerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zimmerman, Thomas P., et al.. (2019). Immunoglobulin G from single plasma donor in immune globulin intravenous causes false positive pyrogen test. Biologicals. 59. 12–19. 2 indexed citations
2.
Zimmerman, Thomas P.. (2006). Yield improvement for manufacture of α1‐proteinase inhibitor. Vox Sanguinis. 91(4). 309–315. 2 indexed citations
3.
Mahony, William B., Barbara A. Domin, Susan M. Daluge, & Thomas P. Zimmerman. (2004). Membrane permeation characteristics of abacavir in human erythrocytes and human T-lymphoblastoid CD4+ CEM cells: comparison with (−)-carbovir. Biochemical Pharmacology. 68(9). 1797–1805. 19 indexed citations
4.
Russell, Steven T., Thomas P. Zimmerman, Barbara A. Domin, & Michael J. Tisdale. (2004). Induction of lipolysis in vitro and loss of body fat in vivo by zinc-α2-glycoprotein. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1636(1). 59–68. 124 indexed citations
5.
Novokhatny, Valery, et al.. (2004). Locally delivered plasmin: why should it be superior to plasminogen activators for direct thrombolysis?. Trends in Pharmacological Sciences. 25(2). 72–75. 23 indexed citations
6.
Porter, David, et al.. (1994). 5-Ethynyl-2(1H)-pyrimidinone: Aldehyde oxidase-activation to 5-ethynyluracil, a mechanism-based inactivator of dihydropyrimidine dehydrogenase. Biochemical Pharmacology. 47(7). 1165–1171. 14 indexed citations
7.
Domin, Barbara A., William B. Mahony, & Thomas P. Zimmerman. (1993). Transport of 5-fluorouracil and uracil into human erythrocytes. Biochemical Pharmacology. 46(3). 503–510. 40 indexed citations
8.
Domin, Barbara A., William B. Mahony, & Thomas P. Zimmerman. (1991). Desciclovir permeation of the human erythrocyte membrane by nonfacilitated diffusion. Biochemical Pharmacology. 42(1). 147–152. 13 indexed citations
9.
Mahony, William B., Barbara A. Domin, & Thomas P. Zimmerman. (1991). Ganciclovir permeation of the human erythrocyte membrane. Biochemical Pharmacology. 41(2). 263–271. 41 indexed citations
10.
Wolberg, Gerald, et al.. (1989). Inhibition of neutrophil adherence to endothelial cells by 3-deazaadenosine. Inflammation Research. 27(3-4). 398–400. 6 indexed citations
11.
Prus, Karen, et al.. (1989). 3-Deazaadenosine 5′-triphosphate: A novel metabolite of 3-deazaadenosine in mouse leukocytes. Biochemical Pharmacology. 38(3). 509–517. 12 indexed citations
12.
Zimmerman, Thomas P., Karen Prus, William B. Mahony, & Barbara A. Domin. (1989). 3′-Azido-3′-Deoxythymidine and Acyclovir: Antiviral Nucleoside Analogues with Unusual Cell Membrane Permeation Properties. Advances in experimental medicine and biology. 253B. 399–406. 7 indexed citations
13.
Iannone, Marie A., Gerald Wolberg, & Thomas P. Zimmerman. (1989). Chemotactic Peptide Induces cAMP Elevation in Human Neutrophils by Amplification of the Adenylate Cyclase Response to Endogenously Produced Adenosine. Journal of Biological Chemistry. 264(34). 20177–20180. 65 indexed citations
14.
Mahony, William B., Barbara A. Domin, Randy T. McConnell, & Thomas P. Zimmerman. (1988). Acyclovir transport into human erythrocytes.. Journal of Biological Chemistry. 263(19). 9285–9291. 54 indexed citations
15.
Mahony, William B. & Thomas P. Zimmerman. (1986). Assay for inhibitors of nucleoside transport based upon the use of 5-(/sup 125/I)IODO-2'-deoxyuridine (IdUrd) as permeant. Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States). 1 indexed citations
16.
Zimmerman, Thomas P., et al.. (1980). Modulation of cyclic AMP metabolism by S-adenosylhomocysteine and S-3-deazaadenosylhomocysteine in mouse lymphocytes.. Proceedings of the National Academy of Sciences. 77(10). 5639–5643. 52 indexed citations
17.
Zimmerman, Thomas P., et al.. (1979). Potentiation by homocysteine of adenosine-stimulated elevation of cellular adenosine 3′,5′-monophosphate. Biochemical Pharmacology. 28(15). 2375–2379. 12 indexed citations
18.
Zimmerman, Thomas P.. (1979). Nucleoside 3′,5′-cyclic monophosphate metabolites of purine analogs. Biochemical Pharmacology. 28(17). 2533–2539. 7 indexed citations
19.
Wolberg, Gerald, Thomas P. Zimmerman, Gail S. Duncan, Kay H. Singer, & Gertrude B. Elion. (1978). Inhibition of lymphocyte-mediated cytolysis by adenosine analogs. Biochemical Pharmacology. 27(10). 1487–1495. 37 indexed citations
20.
Zimmerman, Thomas P., L.‐C. Chu, Christopher J.L. Buggé, et al.. (1974). Formation of 5′-nucleotides of 6-methylmercaptopurine ribonucleoside in human tissues in vitro. Biochemical Pharmacology. 23(19). 2737–2749. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D B Wasson Breakdown of academic impact, for papers by L. Lee Bennett Breakdown of academic impact, for papers by Joel V. Tuttle Breakdown of academic impact, for papers by George W. Koszalka Breakdown of academic impact, for papers by Gurpreet S. Ahluwalia Breakdown of academic impact, for papers by Yutaka Natsumeda Breakdown of academic impact, for papers by Mary Sue Colemán Breakdown of academic impact, for papers by Mahmoud H. el Kouni Breakdown of academic impact, for papers by G. A. LePage Breakdown of academic impact, for papers by Jiří Veselý
Rankless by CCL
2026